Is treating Blood pressure alone enough to protect your
Is treating Blood pressure alone enough to protect your
Is treating Blood pressure alone enough to protect your
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Treating a Single Risk Fac<strong>to</strong>r is Not Enough:<br />
Event (%)<br />
f Primary E<br />
Risk of<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Risk reduction (%) Events not avoided (%)<br />
CV Risk 64<br />
Remains Even After<br />
75<br />
72<br />
86<br />
Antihypertensive Therapy in<br />
Placebo-Controlled 36<br />
Studies<br />
SHEP (chlorthalidone<br />
+/- atenolol)<br />
25<br />
MRC-O (HCTZ +<br />
atenolol)<br />
14<br />
Syst-Eur (nitrendipine,<br />
enalapril, HCTZ)<br />
28<br />
PROGRESS<br />
(perindopril +/-<br />
diuretic)<br />
SHEP Cooperative Research Group. JAMA. 1991;265:3255-3264. MRC Working Party. BMJ. 1992;304:405-412.<br />
Staessen JA et al, for the Syst-Eur Trial Investiga<strong>to</strong>rs. Lancet. 1997;350<br />
350:757-764. PROGRESS Collaborative Group.<br />
Lancet. 2001;358:1033-1041.
Change language